Back to Flash News

Anthropic Establishes Public Benefit Fund with Initial Injection of 5% Shares

Anthropic announced the establishment of the Anthropic Public Benefit Fund, committing an initial injection of 5% of the company's shares, with a mechanism that increases as the company's valuation grows.

When the company's valuation rises by 50% above the baseline, the board may discretionarily add an additional 2% of shares. The fund is registered as a wholly-owned limited liability company rather than a traditional nonprofit organization to maintain flexibility in donation forms.

Anthropic has made a clear commitment that the equity held by the fund will never be used for political lobbying or political donations in the U.S. or abroad.

The fund aims to explore public welfare paths on a larger scale, including addressing potential labor market impacts caused by AI, for which the company has already invested $200 million.

Combined with the co-founders' commitment to donate 80% of their personal shares and the employee matching donation plan, along with this injection, it is expected that about 20% of Anthropic's total shares will be dedicated to public benefit, with potential increases if specific valuation milestone ratios are reached.

From a market perspective, this structure directs part of the equity value towards public welfare, shifting funds from shareholder returns to specific public projects, benefiting areas related to the impact of AI on the labor force, while traditional shareholders face potential dilution pressure.

Additional information indicates that this commitment requires shareholder approval, and the company stated it will disclose details on fund governance, structure, and valuation thresholds in the coming months.

Source: Public Information

ABAB AI Insight

As the developer of Claude, Anthropic initially focused on safety and interpretability research, with co-founders committing to donate 80% of their shares at the founding and establishing an employee matching donation plan, emphasizing a historical path that binds company growth to public benefit.

The capital path is reflected in the initial 5% share injection into a wholly-owned LLC public benefit fund, with a mechanism for an additional 2% increase for every 50% rise in valuation, expanding resources from internal research to external donations and direct allocations, while excluding political uses.

Similar cases include other tech companies using incremental executive compensation or equity mechanisms for charitable or social impact projects, as well as mission-oriented allocations under public benefit company structures, with the current AI industry transitioning from technology development to addressing labor market and social impact challenges.

Essentially, this represents capital concentration: directing part of the company's value growth towards public benefit through equity commitments, with a mechanism that allows the fund's scale to expand with valuation, while maintaining flexibility in LLC form, ensuring continuous funding for AI-related social impact projects.

ABAB News · Cognitive Law

  1. The equity increment mechanism can direct growth towards public welfare, rather than being limited to executive compensation.

  2. The LLC form provides donation flexibility while excluding political uses.

  3. The combined commitments of founders and employees can bind a significant proportion of total shares to public benefit.